nedaplatin: Clinical Trials

11 trials of nedaplatin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown, 2 recruiting, 1 completed. 11 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Unknown 8, Recruiting 2, Completed 1
Phase 22Unknown 2

Follow nedaplatin: new trials by email Literature Review of nedaplatin trials Research Report on nedaplatin

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC
Pembrolizumab, Cisplatin, Carboplatin - Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy
Phase 3RecruitingBeijing Tongren Hospital2722023-05-012023-10-30
First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm Trial
Sintilimab - Advanced Non-squamous Non-Small-Cell Lung Cancer
Phase 3UnknownQianfoshan Hospital602021-12-012022-12-13
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma
Docetaxel, nedaplatin, fluorouracil, Docetaxel, cisplatin, fluorouracil, Nedaplatin - Nasopharyngeal Carcinoma
Phase 3RecruitingAffiliated Cancer Hospital & Institute of Guangzhou Medical University3522020-08-012022-05-10
Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
docetaxel, nedaplatin, and capecitabine, nedaplatin, docetaxel, cisplatin, and fluorouracil - Nasopharyngeal Carcinoma
Phase 3UnknownSun Yat-sen University6322018-06-012018-05-11
Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer
Docetaxel, Nedaplatin, Cisplatin - Non-Small Cell Lung Cancer
Phase 3UnknownGuangdong Association of Clinical Trials4882015-10-012015-12-31
Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
Nedaplatin, Cisplatin - Nasopharyngeal Carcinoma
Phase 3UnknownHe Xia1202014-12-012014-12-08
Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma
Adjuvant Chemoradiation, Adjuvant Radiation, Paclitaxel - Esophageal Neoplasms, Esophageal Cancer
Phase 2 / Phase 3UnknownZefen Xiao3602014-10-012020-04-03
Curative Study of Chinese Traditional Medicine to Treat Lung Cancer
JinFuKang, XingZaoRuanJian, pemetrexed,docetaxel,gemcitabine,paclitaxel or vinorelbine combined with carboplatin、cis-platinum or nedaplatin - Cancer
Phase 2 / Phase 3UnknownShanghai University of Traditional Chinese Medicine1202014-09-012017-10-10
The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
Celecoxib, Nedaplatin, Concurrent Radiotherapy - Nasopharyngeal Carcinoma
Phase 3UnknownChangjie Huang1202014-01-012015-09-02
Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma
Nedaplatin, Cisplatin - Nasopharyngeal Carcinoma
Phase 3CompletedSun Yat-sen University4022012-02-012016-10-28
A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
nedaplatin and docetaxel, cisplatin and docetaxel - Nasopharyngeal Carcinoma
Phase 3UnknownGuangxi Medical University22011-11-012011-11-28

Conditions studied

Nasopharyngeal Carcinoma (6)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Esophageal Neoplasms (1)  ·  Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Sun Yat-sen University (2)  ·  Affiliated Cancer Hospital & Institute of Guangzhou Medical University (1)  ·  Beijing Tongren Hospital (1)  ·  Changjie Huang (1)  ·  Guangdong Association of Clinical Trials (1)  ·  Guangxi Medical University (1)  ·  He Xia (1)  ·  Qianfoshan Hospital (1)  ·  Shanghai University of Traditional Chinese Medicine (1)  ·  Zefen Xiao (1)

Countries

China (9)

Top investigators

Changjie Huang (1)  ·  Degan Lu, professor (1)  ·  HaiQiang Mai, MD,Ph.D (1)  ·  Jinquan Liu, M.D (1)  ·  Wu Fang, M.D. (1)  ·  Zefen Xiao, MD (1)  ·  Zhigang Huang (1)

Results publications

PMID 21277552, PMID 29229461, PMID 29501366, PMID 30119083, PMID 30285222, PMID 30955977, PMID 31378236, PMID 31402780, PMID 31560378, PMID 32070309, PMID 32781263, PMID 32997907, PMID 34358724, PMID 34928359, PMID 36158699